Announcements Trials
Browse Landscape

Phase

Phase 3 8Phase 2 5Phase 1 5Phase 1/2 2Phase 4 1

Status

Completed 38Withdrawn 9Active not recruiting 8Recruiting 6Unknown 5Terminated 5Not yet recruiting 2

Sponsor Class

OTHER 4NIH 1

Study Type

Interventional 5

Sponsor

Cancer Type

Genitourinary 4Breast 1

Conditions

Prostatic Neoplasms 4Triple Negative Breast Neoplasms 1Recurrence 1Bulbo-Spinal Atrophy, X-Linked 1Breast Neoplasms 1

Interventions

Cyclophosphamide 166Docetaxel 154Bevacizumab 153Carboplatin 148Gemcitabine 146Cisplatin 146pembrolizumab 142Radiotherapy 135Paclitaxel 132Capecitabine 122Rituximab 115Oxaliplatin 104Fluorouracil 103Nivolumab 94Irinotecan 85Doxorubicin 85Pemetrexed 83Leucovorin 82Dexamethasone 82fludarabine 74fludarabine phosphate 72Bortezomib 69Etoposide 67Erlotinib Hydrochloride 66Cetuximab 65Methotrexate 58Trastuzumab 56Cytarabine 54Lenalidomide 50Everolimus 49

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2 × Terminated × bicalutamide × Clear all
NCT02582749 2022-07-11

Androgen Deprivation Therapy +/- Radium-223 Dichloride in Metastatic Prostate Cancer With Bone Metastases

Hoosier Cancer Research Network

Phase 2 Terminated
16 enrolled 6 charts
Genitourinary

Prostatic Neoplasms

NCT02348281 2018-01-23

Bicalutamide as A Treatment in AR-positive Metastatic Triple-Negative Breast Cancer (mTNBC) Patients

Fudan University

Phase 2 Terminated
1 enrolled
Breast

Breast Neoplasms, Bulbo-Spinal Atrophy, X-Linked, Triple Negative Breast Neoplasms

NCT01200810 2017-12-02

Bicalutamide and RO4929097 in Treating Patients With Previously Treated Prostate Cancer

National Cancer Institute (NCI)

Phase 2 Terminated
10 enrolled 7 charts
Genitourinary

Prostatic Neoplasms

NCT00521781 2016-03-17

Study of Abraxane Plus Hormonal Therapy as Initial Treatment of Unresectable or Metastatic Prostate Cancer

The Methodist Hospital Research Institute

Phase 2 Terminated
14 enrolled
Genitourinary

Prostatic Neoplasms

NCT01531205 2014-11-05

Neoadjuvant Chemohormonal Therapy Followed by Salvage Surgery for High Risk PSA

H. Lee Moffitt Cancer Center and Research Institute

Phase 2 Terminated
2 enrolled 6 charts
Genitourinary

Prostatic Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡